{
  "title": "Paper_519",
  "abstract": "pmc J Nat Prod J Nat Prod 822 acssd np Journal of Natural Products 0163-3864 1520-6025 pubs.acs.org/jnp pmc-is-collection-domain yes pmc-collection-title ACS AuthorChoice PMC12481561 PMC12481561.1 12481561 12481561 40940010 10.1021/acs.jnatprod.5c00757 1 Article Structure Determination\nand Biosynthesis of Dapalides\nA–C, Glycosylated Kahalalide F Analogues from the Marine Cyanobacterium Dapis 7715269 Ellis Emma K. 2969291 https://orcid.org/0000-0002-9288-6405 Ióca Laura P. 7715271 Liu Jie 4731551 https://orcid.org/0000-0001-6803-044X Chen Manyun 183416 https://orcid.org/0000-0002-0522-480X Bruner Steven D. 78830 https://orcid.org/0000-0001-8610-0659 Ding Yousong 772063 https://orcid.org/0000-0002-4691-1569 Paul Valerie J. 1108990 Donia Mohamed S. 743179 https://orcid.org/0000-0002-4091-7492 Luesch Hendrik  † Department\nof Medicinal Chemistry 3463 University of Florida 1345 Center Drive Gainesville Florida 32610 United States  ‡ Center\nfor Natural Products, Drug Discovery, and Development 3463 University of Florida 1345 Center Drive Gainesville Florida 32610 United States  § Department\nof Molecular Biology 6740 Princeton University Princeton New Jersey 08544 United States  ∥ Department\nof Chemistry 3463 University of Florida Gainesville Florida 32611 United States  ⊥ Smithsonian\nMarine Station 701 Seaway\nDrive Fort Pierce Florida 34949 United States  # Program\nin\nCancer and Stem Cell Biology Duke-NUS Medical\nSchool Singapore 169857 Singapore * donia@princeton.edu * luesch@cop.ufl.edu 26 8 2025 26 9 2025 88 9 497980 2138 2150 19 6 2025 13 8 2025 12 8 2025 26 8 2025 30 09 2025 01 10 2025 01 10 2025 © 2025 The Authors. Published by American Chemical Society and American Society of Pharmacognosy 2025 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/ This article is licensed under CC-BY-NC-ND 4.0 Kahalalides were originally isolated from the marine\nmollusk Elysia rufescens Bryopsis Candidatus Bryopsis 1 3 Dapis 1 dap Dapis 1 National Institute of General Medical Sciences 10.13039/100000057 R35GM128742 National Institute of General Medical Sciences 10.13039/100000057 RM1GM145426 National Institute of General Medical Sciences 10.13039/100000057 T32GM136583 Debbie and Sylvia DeSantis Chair Professorship NA NA pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement yes pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes document-id-old-9 np5c00757 document-id-new-14 np5c00757 production-flag-MathML-config-version 3 production-flag-journal-citation-display-style acs-no-titles production-flag-journal-date-display-style dates-used-rcd-rvd-acc production-flag-si-avail yes document-id-alt-64 8e9f7074206135a3dbd8187b84d5c1c049a667263d9945936bce0186759a848e Marine organisms produce specialized\nmetabolites with structural diversity, complexity, and various biological\nactivity. Decades of explorations of marine micro- and macroorganisms\nhave culminated into the discovery of over 40,000 marine natural products\n(MNPs) and the development of 15 FDA approved drugs for various indications.     Dolabella auricularia Caldora penicillata  Theonella\nswinhoei   Elysia rufescens Bryopsis Candidatus Bryopsis The kahalalides\nare a distinct class of depsipeptides, containing\nboth l d N     in vivo     In our ongoing research efforts to aid in the discovery of\nnew\nbioactive molecules from marine cyanobacteria, we report three new\nkahalalide F analogues, dapalides A-C ( 1 3 Figure Dapis 1 Structures\nof kahalalide F and dapalides A–C ( 1 3 1 2 3 1 Results and Discussion The marine cyanobacterial sample\nVPG23-80 was collected from patch\nreefs inside Cocos Lagoon, Guam. The freeze-dried sample was extracted\nwith 1:1 EtOAc:MeOH, then subjected to solvent–solvent partitioning,\nsilica gel chromatography, and reversed-phase HPLC, yielding dapalide\nA ( 1 2 3 1 1 1 -d 6 Dapalide A ( 1 76 131 13 24 m z + 1  H  C  H  H/C  C  H/C Table d 6 1 1 Table Figure  H  C  H  C  H  C  H  C 2 a) Key\nCOSY (blue), HMBC (red), and ROESY (dashed) 2D NMR correlations\nfor dapalide A ( 1 1 NMR Spectroscopic Data for Dapalide\nA ( 1 d 6 Amino Acid Position δ H J δ C COSY HMBC TOCSY ROESY Val-1 1  169.2, C  2, 3, 5    2 3.85, dd (10.0, 9.0) 59.9, CH 6, 3 1, 3, 4, 5 6, 3, 4, 5   3 1.37, ov. 29.3, CH 2, 4, 5 2 6, 2, 4, 5   4 0.64, d (6.5) 18.89, CH 3 3 2, 3, 5 6, 2, 3, 5   5 0.58, d (6.5) 18.2, CH 3 3 2, 3, 4 6, 2, 3, 4   6 6.75, d (9.0) NH 2 2, 7 2, 3, 4, 5, 7 1, 5 Dbu 7  163.2, C  2, 6, 9, 10, 11    8  130.2, C  9, 10    9 6.46, dq (7.1, 1.1) 129.4, CH 11, 10 8, 10 11, 10 11  10 1.67, d (7.1) 12.4, CH 3 9 9 11, 9, 8 11  11 9.95, s NH 2 8, 12 2, 3, 4, 5 11, 5 Ile-1 12  172.1, C  11, 13    13 3.91, dd (10.4, 5.8 58.3 CH 14, 18 14, 15, 16 15, 16, 17, 18 18  14 1.83, ov. 32.8, CH 13, 15, 16 13, 15, 16 13, 15, 16, 17, 18 18  15 1.54, ov. 24.3, CH 2 14, 17 14, 16, 17 13, 14, 16, 17, 18    1.24, ov.  14, 17 14, 16, 17 13, 14, 16, 17, 18   16 0.9, d (6.7) 14.7, CH 3 13 14, 15,\n17 13, 14, 15, 17, 18   17 0.835, ov. 9.3, CH 3 15 13, 14, 15 13, 14, 15, 16, 18   18 8.78, d (5.8) NH 13 13, 19 13,\n14, 15, 16, 17, 18 13, 14, 20, 21 Ile-2 19  172.8,\nC  18, 20    20 4.57, dd\n(8.9, 4.5) 53.0, CH 21, 25 21, 22, 23, 26, 10, 21, 22, 24, 23 18  21 1.99, ov, 39.4, CH 20, 22, 23 20 10, 20, 22, 24, 23 18  22 1.25, ov. 26.1, CH 2 21, 24 20, 24, 23 10, 20, 21, 22, 24,\n23    1.01, ov.  21, 24 20, 24, 23 10, 20, 21, 22, 24,\n23   23 0.74, d (6.3) 13.7, CH 3 21 20, 21, 22 10, 20, 21, 22, 24   24 0.93,\nt (7.4) 11.8, CH 3 21 21, 22 10, 20, 21, 22, 23   25 7.48, d (8.9) NH 20 20, 26 20,\n21, 22, 24, 23 27, 32 Leu 26  171.1, C  10, 24    27 4.38, ov. 29.1, CH 28, 32 26, 28 28, 29, 30, 31, 32 25  28 1.53, ov. 42.4, CH 2 27, 29 27 27, 29, 30, 31, 32 25   1.37, ov.  27, 29 27, 30, 31 27, 29, 30, 31, 32   29 1.28, ov. 23.9, CH 28, 30, 31 26,\n30, 31 27, 28, 30, 31, 32   30 0.825, d (6.2) 23.1, CH 3 29 28, 29 27, 29, 28, 31, 32   31 0.808, d (6.2) 20.9,\nCH 3 29 28, 29 27, 29, 28, 30, 32   32 8.89, d (10.0) NH 27 27, 33 27, 28, 29, 30, 31 25, 34 Thr-1 33  168.0, CH  32, 34    34 4.43, dd (10.2, 9.0) 56.0, CH 35,\n37 33, 35, 36, 37, 38 35, 36, 37 32, 37, 44  35 4.98, dd (6.4, 10.2) 69.4, CH 34,\n36 34, 36, 88, 90 34, 36, 37   36 1.07, d\n(6.4) 16.5, CH 3 35 34, 35, 37 35, 34, 37   37 8.57, d, 9.0 NH 34 34, 38 34, 35, 36 34, 39, 44 Ile-3 38  169.3, C  37, 39    39 4.36, dd (8.5, 5.6) 55.6, CH 44 38, 40, 41, 40, 41, 42, 43, 44 37  40 1.69,\nov. 37.1, CH 41 39, 41, 42, 43 39, 41, 42, 43, 44   41 1.32,\nov. 25.2, CH 2 40, 43 39, 40, 42, 43 39, 40, 42,\n43, 44    1.05, ov.  40, 43 39, 40, 42, 43 39, 40, 42, 43,\n44   42 0.81, d (6.8) 11.4, CH 3 41 41 39, 40, 41, 42, 44   43 0.78, d\n(6.8) 14.0, CH 3 40 39, 40, 41 39, 40, 41, 42, 43   44 7.59, d (8.5) NH 39 39, 45 39,\n40, 41, 42, 43 34, 37, 46, 47, 49 Ser 45  170.9, C  44, 46    46 4.35, ov. 54.6, C 47, 49 45, 47, 48 47, 48, 49 44  47 3.53, ov. 61.8, CH 2 46, 48 46, 50 47, 48, 49 44   3.49, ov.  46, 48 46, 50 47, 48, 49 44  48 4.85, t (5.3) OH 47 46, 47 46, 47, 49   49 7.83, d (8.0) NH 46 46, 50 46,\n47, 48 44, 28 Pro 50  171.5, C  47, 49, 51    51 4.44, ov. 59.3, CH 52 52, 53 52, 53, 54 49  52 2.01, ov. 29.0, CH 2 53 50 51, 53, 54    1.81, ov.  53 50 51, 53, 54   53 1.9,\nov. 24.0, CH 2 54, 52 52, 54 51, 52, 54    1.81,\nov.  54, 52 52, 54 51, 52, 54   54 3.7, w.p. 46.8, CH 2 53 53 51, 52, 53    3.55, w.p.  53 53 51,\n52, 53  Val-2 55  171.0, C  56    56 4.35, ov. 55.3, CH 57, 60 34, 42, 45, 55    57 1.97, ov. 29.9, CH 56 56, 58, 59 56, 58, 59, 60   58 0.89,\nd (6.8) 18.97, CH 3 57 56, 57, 59 56, 57, 59   59 0.84, ov. 18.0, CH 57 57,\n58, 56 56, 57, 58   60 7.80, d (8.0) NH 56 56, 61 56, 57, 58, 59 62, 63, 71 Thr-2 61  169.3, C  60, 62    62 4.29, dd (8.2, 3.2) 57.6, CH 8,\n29 61, 65, 66 61, 63, 65, 66 60  63 4.03,\nov. 66.5, CH 27, 62.5, 16 62, 64, 65 61, 62, 65, 66 60  64 1.02, d (6.2) 19.3, CH 3 29 62, 63 62, 63, 65, 66   65 4.89, d (4.7) OH 29 61, 62, 63 61, 62,\n63, 66   66 7.73, d (8.2) NH 27 62, 67 61, 62, 63, 65 68, 71, 31 Thr-3 67  169.4, C  66, 68    68 4.37,\ndd (8.0, 4.3) 57.4, CH 69, 72 67,70, 71, 72 69, 70, 71, 72 66  69 3.96, ov. 66.2, CH 68, 70, 71  68, 69, 71, 72 66  70 1.02, d (6.2) 18.96, CH 3 69 68, 69, 71 68, 69, 71, 72   71 5.09, d (4.8) OH 69 68, 70 68, 69, 70, 72 60, 66  72 8.14,\nd (8.0) NH 68 68, 73 68, 69, 70, 71 66, 75, 77 Thr-4 73  169.1, C  72, 74    74 4.73, dd (8.5, 4.2) 55.7, CH 77, 75 73, 75, 76, 75, 76, 77 31  75 3.97, ov. 75.6, CH 74, 76 1′, 73,\n76 74, 76, 77   76 1.11, d (6.5) 16.5,\nCH 3 75 74, 75 74, 75, 77   77 8.07, d (8.5) NH 74 74, 78 74, 75, 76 31, 1′,\n2″ Glc 1′ 4.95, d (3.8) 99.0, CH 2′ 75, 2″ 2′, 2″, 3′,\n3″, 4″, 6′ 2′  2′ 3.09, ddd (9.2,\n9.2, 3.8) 72.0, CH 1′, 2″,\n3′  1′, 2″, 3′,\n3″, 4′, 4″,\n5′, 6″ 1′, 4′  2″ 4.23, d (9.2) OH 2′ 1′ 1′, 2′, 3″, 4′, 5′, 6′ 3′  3′ 3.29, ddd (9.2, 9.2, 3.6) 73.5, CH 3″, 4′,  1′, 2′,\n2″, 3″, 4′, 4″,\n5′, 6″ 2″, 4″, 5′  3″ 4.70, d (4.8) OH 3′  1′,\n2′, 2″, 3′, 4″, 6′,   4′ 3.02, ddd (9.2, 9.2, 4.8) 69.9, CH 3′,\n5′ 6′ 1′, 2′,\n2″, 3′, 3″, 4″,\n5′, 6″ 2′, 6′, 6″  4″ 4.81, d (4.8) OH 4′ 3′, 4′ 1′, 2′, 2″, 3′, 3″, 6′ 3′  5′ 3.42, dd (9.2, 5.2) 31.7, CH 4′,\n6′ 6″ 1′, 2′,\n2″, 3′, 3″, 4′,\n4″, 6″ 3′  6′ 3.59, dd (−9.0, 5.2) 60.5, CH 2 6″  4′, 4″, 6″ 4′   3.43, d (−9.0)  6″  4′,\n4″, 6″ 4′, 76  6″ 4.43, br s OH 6′ 6′ 3′, 3″, 4″, 5′,\n6′ 4′ Oaa 78  173.09, C  77, 79    79 2.19, m 34.9, CH 2 80 78 80, 81   80 1.48,\nov. 25.0, CH 2 79, 81  79, 81   81 1.25, ov. 28.29, CH 2  82 79, 80   82 1.25, ov. 28.29, CH 2  81, 83    83 1.23, ov. 31, CH 2  82,\n84    84 1.24, ov. 21.8, CH 2  83, 85    85 0.85, ov. 13.7, CH 3 84 83, 84   a 600 MHz ( 1 b Deduced from HSQC and HMBC. c NMR signal overlaps with other protons. d Signal is underneath the water\npeak. To selectively isolate the coupling constants of the\nsugar moiety\nto establish the relative configuration, a 1D selective TOCSY NMR\nexperiment was conducted, irradiating the H-2′ proton (δ  H Figure S6 Figure S6 Figure C  Figure  H  C  H  H  C 2  C  C 3 Z  1) Thr Val To verify the structure of 1 1 + 2 + 3 + 4 + 5 + 8 + Figure 3 Structural verification\nof dapalides A–C ( 1 3 The same extract yielded dapalide B ( 2 2 76 133 13 25 m z + Table 2 1  H  H 1 Figure + 2 + 2 + 5 + 8 + 2 NMR Spectroscopic Data for Dapalides\nB ( 2 3 d 6 Dapalide\nB ( 2 Dapalide\nC ( 3 Amino Acid Position δ H J δ C Amino Acid Position δ H J δ C Val-1 1   Val-1 1  169.2, C  2 3.85, t (10.0) 66.8,\nCH  2 3.85, dd (10.0, 9.0) 59.9, CH  3 1.37, ov. 27.7, CH  3 1.37, ov. 29.3, CH  4 0.64, d (6.5) 16.7, CH 3  4 0.64, d (6.5) 18.89,\nCH 3  5 0.58, d (6.5) 18.2, CH 3  5 0.58, d (6.5) 18.2, CH 3  6 6.75, d\n(9.0) NH  6 6.75, d (9.0) NH Thr-1    Dbu 7  163.2, C  8 4.24, d (7.8) 57.8,\nCH  8  130.2,\nC  9 3.90, ov. 66.6, CH  9 6.46, dq (7.1, 1.1) 129.4, CH  10 1.07, ov. 19.7, CH 3  10 1.67, d (7.1) 12.4,\nCH 3  11 7.88, d (7.8) NH  11 9.95, s NH Ile-1 12   Ile-1 12  172.1, C  13 4.47 dd (9.0, 4.5) 53.9, CH  13 3.91, dd (10.4,\n5.8 58.3 CH  14 1.83, ov. 36.7, CH  14 1.83, ov. 32.8, CH  15 1.49, ov. 24.8, CH 2  15 1.54, ov. 24.3, CH 2   1.35, ov.    1.24, ov.   16 0.92,\nov. 14.9, CH 3  16 0.9, d (6.7) 14.7, CH 3  17 0.81, ov. 10.0, CH 3  17 0.835, ov. 9.3, CH 3  18 7.63, d (9.0) NH  18 8.78, d (5.8) NH Ile-2 19  172.8, C Ile-2 19  172.8, C  20 4.57, dd (8.9, 4.5) 53.0, CH  20 4.57, dd (8.9, 4.5) 53.0, CH  21 1.99, ov. 39.4, CH  21 1.99, ov. 39.4, CH  22 1.25, ov. 26.1, CH 2  22 1.25, ov. 26.1, CH 2   1.01, ov.    1.01, ov.   23 0.74, d (6.3) 13.7, CH 3  23 0.74, d (6.3) 13.7, CH 3  24 0.93, t (7.4) 11.8, CH 3  24 0.93, t (7.4) 11.8, CH 3  25 7.48, d (8.9) NH  25 7.48, d (8.9) NH Leu 26  171.1, C Leu 26  171.1, C  27 4.38, ov. 29.1, CH  27 4.38, ov. 29.1, CH  28 1.53, ov. 42.4, CH 2  28 1.53, ov. 42.4, CH 2   1.37, ov.    1.37, ov.   29 1.28,\nov. 23.9, CH  29 1.28, ov. 23.9, CH  30 0.825, d (6.2) 23.1, CH 3  30 0.825, d (6.2) 23.1,\nCH 3  31 0.808, d (6.2) 20.9, CH 3  31 0.808, d (6.2) 20.9, CH 3  32 8.89, d (10.0) NH  32 8.89, d (10.0) NH Thr-2 33  168.0, CH Thr-1 33  168.0, CH  34 4.43, dd (10.2, 9.0) 56.0, CH  34 4.43,\ndd (10.2, 9.0) 56.0, CH  35 4.98, dd (6.4, 10.2) 69.4, CH  35 4.98, dd (6.4, 10.2) 69.4, CH  36 1.07, d (6.4) 16.5, CH 3  36 1.07, d (6.4) 16.5,\nCH 3  37 8.57, d, 9.0 NH  37 8.57, d, 9.0 NH Ile-3 38  169.3, C Ile-3 38  169.3, C  39 4.36, dd (8.5, 5.6) 55.6, CH  39 4.36,\ndd (8.5, 5.6) 55.6, CH  40 1.69, ov. 37.1, CH  40 1.69,\nov. 37.1, CH  41 1.32, ov. 25.2, CH 2  41 1.32, ov. 25.2, CH 2   1.05, ov.    1.05, ov.   42 0.81, d (6.8) 11.4, CH 3  42 0.81, d (6.8) 11.4,\nCH 3  43 0.78, d (6.8) 14.0, CH 3  43 0.78, d (6.8) 14.0, CH 3  44 7.59, d\n(8.5) NH  44 7.59, d (8.5) NH Ser 45  170.9, C Ser 45  170.9, C  46 4.35, ov. 54.6, C  46 4.35, ov. 54.6, C  47 3.53, ov. 61.8, CH 2  47 3.53, ov. 61.8, CH 2   3.49, ov.    3.49, ov.   48 4.85, t (5.3) OH  48 4.85, t (5.3) OH  49 7.83, d (8.0) NH  49 7.83, d (8.0) NH Pro 50  171.5, C Pro 50  171.5, C  51 4.4, ov. 59.3, CH  51 4.4, ov. 59.3, CH  52 2.01, ov. 29.0, CH 2  52 2.01, ov. 29.0, CH 2   1.81, ov.    1.81, ov.   53 1.9,\nov. 24.0, CH 2  53 1.9, ov. 24.0, CH 2   1.81, ov.    1.81, ov.   54 3.7, w.p. 46.8, CH 2  54 3.7, w.p. 46.8, CH 2   3.55, w.p.    3.55, w.p.  Val-2 55  171.0, C Val-2 55  171.0, C  56 4.35, ov. 55.3, CH  56 4.35, ov. 55.3, CH  57 1.97, ov. 29.9, CH  57 1.97, ov. 29.9, CH  58 0.89, d (6.8) 18.97, CH 3  58 0.89, d (6.8) 18.97, CH 3  59 0.84, ov. 18.0, CH  59 0.84, ov. 18.0, CH  60 7.80, d (8.0) NH  60 7.80, d (8.0) NH Thr-3 61  169.3,\nC Thr-2 61  169.3, C  62 4.29, dd (8.2, 3.2) 57.6, CH  62 4.29, dd (8.2, 3.2) 57.6, CH  63 4.03, ov. 66.5, CH  63 4.03, ov. 66.5, CH  64 1.02, d (6.2) 19.3, CH 3  64 1.02, d (6.2) 19.3, CH 3  65 4.89, d\n(4.7) OH  65 4.89, d (4.7) OH  66 7.73, d (8.2) NH  66 7.73, d (8.2) NH Thr-4 67  169.4,\nC Thr-3 67  169.4, C  68 4.37, dd (8.0, 4.3) 57.4, CH  68 4.37, dd (8.0, 4.3) 57.4, CH  69 3.96, ov. 66.2, CH  69 3.96, ov. 66.2, CH  70 1.02, d (6.2) 18.96, CH 3  70 1.02, d (6.2) 18.96, CH 3  71 5.09, d (4.8) OH  71 5.09, d (4.8) OH  72 8.14, d (8.0) NH  72 8.14, d (8.0) NH Thr-5 73  169.1, C Thr-4 73  169.1, C  74 4.73, dd (8.5, 4.2) 55.7, CH  74 4.73, dd (8.5, 4.2) 55.7, CH  75 3.97, ov. 75.6, CH  75 3.97, ov. 75.6, CH  76 1.11, d (6.5) 16.5, CH 3  76 1.11, d (6.5) 16.5, CH 3  77 8.07, d\n(8.5) NH  77 8.07, d (8.5) NH Glc 1′ 4.95, d (3.8) 99.0, CH Glc 1′ 4.95, d (3.8) 99.0, CH  2′ 3.09, ddd (9.2, 9.2, 3.8) 72.0, CH  2′ 3.09, ddd (9.2, 9.2, 3.8) 72.0, CH  2″ 4.23, d (9.2) OH  2″ 4.23, d (9.2) OH  3′ 3.29, ddd (9.2,\n9.2, 3.6) 73.5, CH  3′ 3.29, ddd (9.2, 9.2, 3.6) 73.5, CH  3″ 4.70, d (4.8) OH  3″ 4.70,\nd (4.8) OH  4′ 3.02, ddd (9.2, 9.2, 4.8) 69.9, CH  4′ 3.02, ddd (9.2, 9.2, 4.8) 69.9, CH  4″ 4.81, d (4.8) OH  4″ 4.81, d (4.8) OH  5′ 3.42, dd (9.2,\n5.2) 31.7, CH  5′ 3.42, dd (9.2, 5.2) 31.7, CH  6′ 3.59, dd (−9.0,\n5.2) 60.5, CH 2  6′ 3.59, dd (−9.0, 5.2) 60.5, CH 2   3.43, d (−9.0)    3.43, d (−9.0)   6″ 4.43, br s OH  6″ 4.43, br s OH Oaa 78   Haa 78    79 2.19, m  79 2.19, m 35.4, CH 2  80 1.48, ov.   80 1.48, ov. 24.6, CH 2  81 1.25, ov.   81 1.28, ov. 28.7, CH 2  82 1.25, ov.   82 1.24, ov. 21.8, CH 2  83 1.23, ov.   83 0.85, d (6.2) 13.7, CH 3  84 1.24, ov.       85 0.85, ov.      a 600 MHz ( 1 b Deduced from HSQC and HMBC. c NMR signal overlaps with other protons. d Signal is underneath the water\npeak. Dapalide C ( 3 1 74 127 13 24 m z + 1 1 1 1 1 + 3 + 2 + 1 Figure 3 The analysis of the absolute configuration of dapalide A\n( 1 l d d l d Figure l d allo l d allo Figure d d allo 1 2 3 3 2 l d allo d d Figure l d allo- Figure l d 4 Chemical analysis of the absolute configuration\nof dapalide A ( 1 1 d allo H H H 1 Dapalides A-C ( 1 3 Figure Table Figure Table Ca. 3 Amino Acid Placement of Dapalides\nA–C ( 1 3   FA  A1  A2  A3  A4  A5  A6  A7  A8  A9  A10  A11  A12  A13 Kahalalide F 5MeHaa V D T L V L V D P D O L I D T D I D V D F L DB Z V L Dapalide A Oaa T D T T V P D S L I T L I I T V Dapalide B Oaa T D T T V P D S L I T L I I DB Z V Dapalide C Haa T D T T V P D S L I T L I I DB Z V To identify the BGC for dapalides A-C ( 1 3 Figure 1 Figure d l d 1 Figure Dapis pnigousa MF061807 Dapis pnigousa MF167708 Dapis Figure 1 3 5 Genetic and domain architecture of the dapalide biosynthetic\ngene\ncluster. a) Comparison of the gene architectures between the dapalide\nBGC ( dap dap 6 Phylogenetic tree of the dapalide producing Dapis Overall, the Ca. dap 1 l 2 Dapalide A ( 1 Saccharomyces cerevisiae Figure 1 Figure 7 Antiproliferative activity\nof dapalide A ( 1 Previous extensive SAR evaluation of KF showed\nthat the positions\nof the d Cyanobacteria are a diverse group of ancient\norganisms that have\nproduced several bioactive metabolites. The importance of this work\nlies in the discovery of a new source of kahalalide-like molecules\n- namely free-living marine cyanobacteria - and the structural differences\nbetween kahalalide F and the cyanobacterial metabolites. During\nthe development of this manuscript, the Gerwick laboratory\nreleased a preprint outlining the discovery of other kahalalide F-like\nanalogues from a different genus of cyanobacterium from Panama, Limnoraphis Another dimension\nto the importance of this discovery lies within\nthe relatively new genus producing new types of compounds not characterized\nin the literature. Dapis   Lyngbya Dapis Additionally, a common dilemma that isolation chemists face is\nthe limited amount of material that can be isolated from small collections\nof marine organisms, oftentimes precluding unambiguous structure determination,\nespecially of the absolute configuration. In the case of complex peptides\nsuch as kahalalides or dapalides that are comprised of l d   Experimental Section General Experimental Procedures Optical rotation was\nmeasured on a PerkinElmer 341 polarimeter. NMR data were collected\non a Bruker Avance Neo 600 MHz spectrometer and high resolution Bruker\nAvance Neo 600 MHz 1.7 mm cryoprobe spectrometer, operating at 600\nMHz for 1 H d 6 Cell Culture HCT 116 human colorectal carcinoma cells\nand Hep G2 human hepatocellular carcinoma cells were purchased from\nthe American Type Culture Collection (ATCC, Manassas, VA, USA) and\ncultured in Dulbecco’s Modified Eagle Medium (DMEM) (DMEM,\nInvitrogen, Carlsbad, CA, USA) and Eagle’s Minimum Essential\nMedium (EMEM, Invitrogen, Carlsbad, CA, USA), respectively, supplemented\nwith 10% fetal bovine serum (FBS, Sigma-Aldrich, St. Louis, MO, USA)\nand 1% antibiotic-antimycotic (penicillin, streptomycin, and Gibco\nAmphotericin B, Invitrogen) and maintained under a humidified environment\nwith 5% CO 2 Biological Material The marine cyanobacterium VPG23–80\nwas collected from patch reefs in Cocos Lagoon, Guam on April 4, 2023,\nas an orange-brown filamentous mat. Extraction and Purification The cyanobacterium (VPG23-80)\nwas freeze-dried and extracted at the Smithsonian Marine Station using\na nonpolar extraction with 1:1 EtOAc:MeOH (135.2 mg) and then a polar\nextraction with 30% aq. EtOH (88.44 mg). The nonpolar extract was\nsubjected to solvent partitioning using EtOAc:H 2 2 2 18 2 2 1 t R 2 2 t R 3 1 t R Dapalide A ( 1 White, amorphous solid;\n[α] 20 D c 3 1 Table m z + 76 132 13 24 Dapalide B ( 2 White, amorphous solid\n(30% mixture containing 2 1 Table m z + 76 134 13 25 Dapalide C ( 3 Colorless, amorphous solid\n(7:3 mixture of 3 1 20 D c 3 1 Table m z + 74 128 13 24 Enantioselective LC-MS Analysis of Amino Acids Dapalide\nA ( 1 2 4 l d d l d allo l d allo l d t R l l allo d allo d l d l d l l allo d allo d l d l d Metagenomic DNA Extraction, Sequencing, and Analysis The cyanobacteria sample was stored frozen in RNA later Cell Viability Assays HCT 116 and Hep G2 cells were\nseeded (10,000 cells/well) in 96-well plates and incubated for 24\nh. Cells were then treated in triplicates with varying concentrations\nof dapalide A ( 1 t 0 t 48 t 48 t 0  Saccharomyces cerevisiae An overnight culture of S. cerevisiae 4 1 Supplementary Material This research\nis supported by the NIH grant RM1GM145426 (H.L.,\nY.D., S.D.B., M.S.D., V.J.P.), the NIH grant R35GM128742 (Y.D.), and\nthe Debbie and Sylvia DeSantis Chair professorship (H.L.). E.K.E.\nis supported by NIGMS grant T32GM136583: Chemistry–Biology\nInterface Training Program at the University of Florida. We thank\nthe Guam Department of Agriculture Division of Aquatic and Wildlife\nResources for the research permit (SCR-MPA-23-007) and the University\nof Guam Marine Laboratory (UOGML) for hosting our visit. We thank\nUOGML staff and Jay Houk (Smithsonian Marine Station) for assistance\nwith collections and Jay Houk for extracting this cyanobacterium.\nA portion of this work was performed in the McKnight Brain Institute\nat the National High Magnetic Field Laboratory’s Advanced Magnetic\nResonance Imaging and Spectroscopy (AMRIS) Facility, which is supported\nby the National Science Foundation Cooperative Agreement DMR-2128556\nand the State of Florida. The NMR data\nfor compounds 1 3 www.np-mrd.org https://np-mrd.org/natural_products/NP035140 https://np-mrd.org/natural_products/NP0351407 https://np-mrd.org/natural_products/NP0351408 dap Dapis PX021390 Dapis PX048350 The Supporting Information\nis available free of charge at https://pubs.acs.org/doi/10.1021/acs.jnatprod.5c00757 1D and 2D NMR spectra for all new compounds ( PDF The manuscript\nwas written through contributions of all authors. All authors have\ngiven approval to the final version of the manuscript. E.K.E. and\nL.P.I. contributed equally. The authors\ndeclare no competing financial interest. MarinLit - A database of the marine natural products literature https://marinlit.rsc.org/ Marine\nPharmacology https://www.marinepharmacology.org Carroll A. R. Copp B. R. Davis R. A. Keyzers R. A. Prinsep M. R. Marine\nNatural Products Nat. Prod. Rep. 2022 39 6 1122 1171 10.1039/D1NP00076D 35201245 Salvador-Reyes L. A. Luesch H. Biological\nTargets and Mechanisms of Action of Natural\nProducts from Marine Cyanobacteria Nat. Prod.\nRep. 2015 32 3 478 503 10.1039/C4NP00104D 25571978 PMC4344435 Luesch H. Ellis E. K. Chen Q.-Y. Ratnayake R. Progress in\nthe Discovery and Development of Anticancer Agents from Marine Cyanobacteria Nat. Prod. Rep. 2025 42 2 208 256 10.1039/D4NP00019F 39620500 PMC11610234 Zhou Q. Hotta K. Deng Y. Yuan R. Quan S. Chen X. Advances in Biosynthesis\nof Natural Products from Marine Microorganisms Microorganisms 2021 9 12 2551 10.3390/microorganisms9122551 34946152 PMC8706298 Xu Y. Du X. Yu X. Jiang Q. Zheng K. Xu J. Wang P. Recent Advances in the Heterologous Expression of Biosynthetic\nGene\nClusters for Marine Natural Products Mar. Drugs 2022 20 6 341 10.3390/md20060341 35736144 PMC9225448 Piel J. Bacterial Symbionts:\nProspects for the Sustainable Production of Invertebrate-Derived Pharmaceuticals Curr. Med. Chem. 2006 13 1 39 50 10.2174/092986706775197944 16457638 Pettit G. R. Kamano Y. Herald C. L. Tuinman A. A. Boettner F. E. Kizu H. Schmidt J. M. Baczynskyj L. Tomer K. B. Bontems R. J. The Isolation and\nStructure of a\nRemarkable Marine Animal Antineoplastic Constituent: Dolastatin 10 J. Am. Chem. Soc. 1987 109 22 6883 6885 10.1021/ja00256a070 Luesch H. Moore R. E. Paul V. J. Mooberry S. L. Corbett T. H. Isolation\nof Dolastatin 10 from the Marine Cyanobacterium Symploca J. Nat. Prod. 2001 64 7 907 910 10.1021/np010049y 11473421 Kallifidas D. Dhakal D. Chen M. Chen Q.-Y. Kokkaliari S. Colon Rosa N. A. Ratnayake R. Bruner S. D. Paul V. J. Ding Y. Luesch H. Biosynthesis of Dolastatin 10 in\nMarine Cyanobacteria, a Prototype for Multiple Approved Cancer Drugs Org. Lett. 2024 26 7 1321 1325 10.1021/acs.orglett.3c04083 38330916 PMC10915760 Engene N. Tronholm A. Salvador-Reyes L. A. Luesch H. Paul V. J.  Caldora Penicillata J. Phycol. 2015 51 4 670 681 10.1111/jpy.12309 26327714 PMC4551411 Kobayashi M. Tanaka J. Katori T. Matsuura M. Kitagawa I. Structure\nof Swinholide A, a Potent Cytotoxic Macrolide from the Okinawan Marine\nSponge Theonella Swinhoei Tetrahedron Lett. 1989 30 22 2963 2966 10.1016/S0040-4039(00)99170-6 Bubb M. R. Spector I. Bershadsky A. D. Korn E. D. Swinholide A Is\na Microfilament Disrupting Marine Toxin That Stabilizes Actin Dimers\nand Severs Actin Filaments (*) J. Biol. Chem. 1995 270 8 3463 3466 10.1074/jbc.270.8.3463 7876075 Andrianasolo E. H. Gross H. Goeger D. Musafija-Girt M. McPhail K. Leal R. M. Mooberry S. L. Gerwick W. H. Isolation\nof Swinholide A and Related Glycosylated Derivatives from Two Field\nCollections of Marine Cyanobacteria Org. Lett. 2005 7 7 1375 1378 10.1021/ol050188x 15787510 Ueoka R. Uria A. R. Reiter S. Mori T. Karbaum P. Peters E. E. Helfrich E. J. N. Morinaka B. I. Gugger M. Takeyama H. Matsunaga S. Piel J. Metabolic and Evolutionary\nOrigin of Actin-Binding Polyketides from Diverse Organisms Nat. Chem. Biol. 2015 11 9 705 712 10.1038/nchembio.1870 26236936 PMC7116039 Hamann M. T. Scheuer P. J. Kahalalide F: A\nBioactive Depsipeptide from the Sacoglossan\nMollusk Elysia rufescens Bryopsis J. Am. Chem. Soc. 1993 115 13 5825 5826 10.1021/ja00066a061 Hamann M. T. Otto C. S. Scheuer P. J. Dunbar D. C. Kahalalides: Bioactive\nPeptides from a Marine Mollusk Elysia rufescens Bryopsis J. Org. Chem. 1996 61 19 6594 6600 10.1021/jo960877+ 11667527 Zan J. Li Z. Tianero Ma. D. Davis J. Hill R. T. Donia M. S. A Microbial\nFactory for Defensive Kahalalides in a Tripartite Marine Symbiosis Science 2019 364 6445 eaaw6732 10.1126/science.aaw6732 31196985 PMC12168154 Bonnard I. Manzanares I. Rinehart K. L. Stereochemistry of Kahalalide F J. Nat. Prod. 2003 66 11 1466 1470 10.1021/np030334c 14640520 Jiménez J. C. López-Macià A. Gracia C. Varón S. Carrascal M. Caba J. M. Royo M. Francesch A. M. Cuevas C. Giralt E. Albericio F. Structure–Activity\nRelationship of Kahalalide F Synthetic Analogues J. Med. Chem. 2008 51 16 4920 4931 10.1021/jm8000828 18672864 Shilabin A. G. Kasanah N. Wedge D. E. Hamann M. T. Lysosome and HER3\n(ErbB3) Selective Anticancer Agent Kahalalide F: Semisynthetic Modifications\nand Antifungal Lead-Exploration Studies J.\nMed. Chem. 2007 50 18 4340 4350 10.1021/jm061288r 17696332 PMC4917214 López-Macià À. Jiménez J. C. Royo M. Giralt E. Albericio F. Synthesis and Structure Determination of Kahalalide\nF1,2 J. Am. Chem. Soc. 2001 123 46 11398 11401 10.1021/ja0116728 11707116 Goetz G. Yoshida W. Y. Scheuer P. J. The Absolute\nStereochemistry of Kahalalide\nF Tetrahedron 1999 55 25 7739 7746 10.1016/S0040-4020(99)00410-X Gao J. Hamann M. T. Chemistry and Biology\nof Kahalalides Chem. Rev. 2011 111 5 3208 3235 10.1021/cr100187n 21480581 PMC4895206 Wyer S. Townsend D. M. Ye Z. Kourtidis A. Choo Y.-M. de Barros A. L. B. Donia M. S. Hamann M. T. Recent\nAdvances and Limitations in the Application of Kahalalides for the\nControl of Cancer Biomed. Pharmacother. 2022 148 112676 10.1016/j.biopha.2022.112676 35149387 PMC9004612 Ciavatta M. L. Devi P. Carbone M. Mathieu V. Kiss R. Casapullo A. Gavagnin M. Kahalalide F Analogues from the Mucous\nSecretion of Indian Sacoglossan Mollusc Elysia Ornata Tetrahedron 2016 72 5 625 631 10.1016/j.tet.2015.12.003 Shilabin A. G. Hamann M. T. In Vitro and In\nVivo Evaluation of Select Kahalalide\nF Analogs with Antitumor and Antifungal Activities Bioorg. Med. Chem. 2011 19 22 6628 6632 10.1016/j.bmc.2011.06.050 21839640 PMC3523750 Suárez Y. González L. Cuadrado A. Berciano M. Lafarga M. Muñoz A. Kahalalide F. a New Marine-Derived Compound, Induces\nOncosis in Human Prostate and Breast Cancer Cells Mol. Cancer Ther. 2003 2 9 863 872 14555705 Rademaker-Lakhai J. M. Horenblas S. Meinhardt W. Stokvis E. de Reijke T. M. Jimeno J. M. Lopez-Lazaro L. Lopez Martin J. A. Beijnen J. H. Schellens J. H. M. Phase I Clinical and Pharmacokinetic\nStudy of Kahalalide F in Patients with Advanced Androgen Refractory\nProstate Cancer Clin. Cancer Res. Off. J. Am.\nAssoc. Cancer Res. 2005 11 5 1854 1862 10.1158/1078-0432.CCR-04-1534 15756010 Pardo B. Paz-Ares L. Tabernero J. Ciruelos E. García M. Salazar R. López A. Blanco M. Nieto A. Jimeno J. Izquierdo M. Á. Trigo J. M. Phase I Clinical\nand Pharmacokinetic Study of Kahalalide F Administered Weekly as a\n1-h Infusion to Patients with Advanced Solid Tumors Clin. Cancer Res. 2008 14 4 1116 1123 10.1158/1078-0432.CCR-07-4366 18281545 Hamann M. T. Technology\nEvaluation: Kahalalide F, PharmaMar Curr. Opin.\nMol. Ther. 2004 6 6 657 665 15663330 PMC4941207 Martín-Algarra S. Espinosa E. Rubió J. López J. J. L. Manzano J. L. Carrión L. A. Plazaola A. Tanovic A. Paz-Ares L. Phase II Study of Weekly Kahalalide F in Patients with\nAdvanced Malignant Melanoma Eur. J. Cancer 2009 45 5 732 735 10.1016/j.ejca.2008.12.005 19186051 Molina-Guijarro J. M. Macías Á. García C. Muñoz E. García-Fernández L. F. David M. Núñez L. Martínez-Leal J. F. Moneo V. Cuevas C. Lillo M. P. Villalobos Jorge C. Valenzuela C. Galmarini C. M. Irvalec Inserts into the Plasma Membrane Causing Rapid\nLoss of Integrity and Necrotic Cell Death in Tumor Cells PLoS One 2011 6 4 e19042 10.1371/journal.pone.0019042 21556352 PMC3083409 Ratain M. J. Geary D. Undevia S. D. Coronado C. Alfaro V. Iglesias J. L. Schilsky R. L. Miguel-Lillo B. First-in-Human,\nPhase I Study of Elisidepsin (PM02734) Administered as a 30-min or\nas a 3-h Intravenous Infusion Every Three Weeks in Patients with Advanced\nSolid Tumors Invest. New Drugs 2015 33 4 901 910 10.1007/s10637-015-0247-1 25947566 Petty R. Anthoney A. Metges J.-P. Alsina M. Gonçalves A. Brown J. Montagut C. Gunzer K. Laus G. Iglesias Dios J. L. Miguel-Lillo B. Bohan P. Salazar R. Phase Ib/II\nStudy of Elisidepsin in Metastatic or Advanced Gastroesophageal Cancer\n(IMAGE Trial) Cancer Chemother. Pharmacol. 2016 77 4 819 827 10.1007/s00280-016-2991-0 26964995 Kokkaliari S. Luo D. Paul V. J. Luesch H. Isolation and Biological Activity\nof Iezoside and Iezoside B, SERCA Inhibitors from Floridian Marine\nCyanobacteria Mar. Drugs 2023 21 7 378 10.3390/md21070378 37504909 PMC10381893 Al-Awadhi F. H. Kokkaliari S. Ratnayake R. Paul V. J. Luesch H. Isolation\nand Characterization of the Cyanobacterial Macrolide Glycoside Moorenaside,\nan Anti-Inflammatory Analogue of Aurisides Targeting the Keap1/Nrf2\nPathway J. Nat. Prod. 2024 87 10 2355 2365 10.1021/acs.jnatprod.4c00420 39315953 PMC11519913 Chen X.-Q. Luo Z. Liu K. Tang Z.-Z. Peng L. Gao C. Xia C. Liu Y.-H. A New Ascochlorin Glycoside from Brittlestar-Derived\nFungus Acremonium Rec. Nat. Prod. 2024 1 136 142 10.25135/rnp.438.12310.2940 Li M. Li S. Hu J. Gao X. Wang Y. Liu Z. Zhang W. Thioester-Containing Benzoate Derivatives with α-Glucosidase\nInhibitory Activity from the Deep-Sea-Derived Fungus Talaromyces\nindigoticus Mar. Drugs 2022 20 1 33 10.3390/md20010033 PMC8781869 35049889 Cai W. Matthew S. Chen Q.-Y. Paul V. J. Luesch H. Discovery\nof New A- and B-Type Laxaphycins with Synergistic Anticancer Activity Bioorg. Med. Chem. 2018 26 9 2310 2319 10.1016/j.bmc.2018.03.022 29606488 PMC6084785 Taori K. Matthew S. Rocca J. R. Paul V. J. Luesch H. Lyngbyastatins\n5–7, Potent Elastase Inhibitors from Floridian Marine Cyanobacteria, Lyngbya J. Nat. Prod. 2007 70 10 1593 1600 10.1021/np0702436 17910513 Keller L. Canuto K. M. Liu C. Suzuki B. M. Almaliti J. Sikandar A. Naman C. B. Glukhov E. Luo D. Duggan B. M. Luesch H. Koehnke J. O’Donoghue A.\nJ. Gerwick W. H. Tutuilamides\nA-C: Vinyl-Chloride Containing Cyclodepsipeptides\nfrom the Marine Cyanobacteria Schizothrix Coleofasciculus ACS Chem. Biol. 2020 15 3 751 757 10.1021/acschembio.9b00992 31935054 PMC7480958 Blin K. Shaw S. Steinke K. Villebro R. Ziemert N. Lee S. Y. Medema M. H. Weber T. antiSMASH 5.0: Updates\nto the Secondary Metabolite Genome Mining Pipeline Nucleic Acids Res. 2019 47 W1 W81 W87 10.1093/nar/gkz310 31032519 PMC6602434 Engene N. Tronholm A. Paul V. J. Uncovering\nCryptic Diversity of Lyngbya Dapis J. Phycol. 2018 54 4 435 446 10.1111/jpy.12752 29791035 Martin H. Lazaro L. R. Gunnlaugsson T. Scanlan E. M. Glycosidase Activated\nProdrugs for Targeted Cancer Therapy Chem.\nSoc. Rev. 2022 51 23 9694 9716 10.1039/D2CS00379A 36349720 Ryu B. Avalon N. Cuau M. Almaliti J. Din M. O. Brennan C. Glukhov E. Knight R. Gerwick L. Gerwick W. Cyanobacteria Join the Kahalalide\nConversation: Genome and Metabolite Evidence for Structurally Related\nPeptides 2025 10.26434/chemrxiv-2025-dmqr1 PMC12449831 40828982 Soares A. R. Engene N. Gunasekera S. P. Sneed J. M. Paul V. J. Carriebowlinol,\nan Antimicrobial Tetrahydroquinolinol from an Assemblage of Marine\nCyanobacteria Containing a Novel Taxon J. Nat.\nProd. 2015 78 3 534 538 10.1021/np500598x 25536090 Youssef D. T. A. Mufti S. J. Badiab A. A. Shaala L. A. Anti-Infective Secondary\nMetabolites of the Marine Cyanobacterium Lyngbya Mar. Drugs 2022 20 12 768 10.3390/md20120768 36547915 PMC9788623 Kurisawa N. Iwasaki A. Jeelani G. Nozaki T. Suenaga K. Iheyamides\nA–C, Antitrypanosomal Linear Peptides Isolated from a Marine Dapis J. Nat.\nProd. 2020 83 5 1684 1690 10.1021/acs.jnatprod.0c00250 32352773 Yamazaki Y. Yamabe S. Komori S. Yoshitake K. Fukuoka M. Sato S. Takada K. Structure Determination\nof Kahalalide Analogues Based on Metagenomic Analysis of a Bryopsis J.\nNat. Prod. 2023 86 11 2539 2545 10.1021/acs.jnatprod.3c00760 37889636 Chen J. Jia Y. Sun Y. Liu K. Zhou C. Liu C. Li D. Liu G. Zhang C. Yang T. Huang L. Zhuang Y. Wang D. Xu D. Zhong Q. Guo Y. Li A. Seim I. Jiang L. Wang L. Lee S. M. Y. Liu Y. Wang D. Zhang G. Liu S. Wei X. Yue Z. Zheng S. Shen X. Wang S. Qi C. Chen J. Ye C. Zhao F. Wang J. Fan J. Li B. Sun J. Jia X. Xia Z. Zhang H. Liu J. Zheng Y. Liu X. Wang J. Yang H. Kristiansen K. Xu X. Mock T. Li S. Zhang W. Fan G. Global Marine\nMicrobial Diversity\nand Its Potential in Bioprospecting Nature 2024 633 8029 371 379 10.1038/s41586-024-07891-2 39232160 PMC11390488 Trindade M. van Zyl L. J. Navarro-Fernández J. Abd Elrazak A. Targeted Metagenomics\nas a Tool to Tap into Marine Natural Product Diversity for the Discovery\nand Production of Drug Candidates Front. Microbiol. 2015 6 890 10.3389/fmicb.2015.00890 26379658 PMC4552006 Documentation PacBio https://www.pacb.com/support/documentation/ Kolmogorov M. Bickhart D. M. Behsaz B. Gurevich A. Rayko M. Shin S. B. Kuhn K. Yuan J. Polevikov E. Smith T. P. L. Pevzner P. A. metaFlye: Scalable Long-Read Metagenome\nAssembly Using Repeat Graphs Nat. Methods 2020 17 11 1103 1110 10.1038/s41592-020-00971-x 33020656 PMC10699202 PacificBiosciences/Pb-Metagenomics-Tools 2025 https://github.com/PacificBiosciences/pb-metagenomics-tools ",
  "metadata": {
    "Title of this paper": "PacificBiosciences/Pb-Metagenomics-Tools",
    "Journal it was published in:": "Journal of Natural Products",
    "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12481561/"
  }
}